(Photo = Getty Image Bank)
Major pharmaceutical and bio companies are actively paying out cash dividends ahead of the’shareholders’ meeting season’.
According to the industry on the 17th, Seegene(133,600 +1.98%), Macrogen(34,150 +0.44%), Yuhan Corporation(63,000 +0.16%), Green Cross Holdings(35,850 +2.58%) Major top pharmaceutical companies such as those who decided to pay dividends in cash.
Seegene plans to return a total of 3.89 billion won to shareholders by proceeding with a cash dividend of 1,500 won per common share. This is a significant increase compared to the cash dividend of KRW 100 per share for the first time last year, totaling KRW 2.6 billion.
Macrogen decided on the first cash dividend of 300 won per share, a total of 2.93 billion won, based on the highest performance since its inception last year.
Among the existing pharmaceutical companies, Yuhan Corporation’s cash dividend is the highest at 2.94 billion won.
In addition, Green Cross Holdings 22.7 billion won, GC Green Cross(359,500 +4.51%) 11.7 billion won, Hanmi Science(61,300 -0.16%) 12.94 billion won, Chong Kun Dang(180,500 +7.76%) Cash dividends from major pharmaceutical companies, including 10.8 billion won, followed.
An industry insider said, “This year, sales of bio and diagnostic kit companies increased sharply in the previous year due to the novel coronavirus infection (Corona 19).” I can see it.”
Eunji Cha, reporter Hankyung.com [email protected]
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution